Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets

Documenti analoghi

• Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study
  di: Tobias Moser, et al.
  Pubblicazione: (2024)
• Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti‐CD20 therapy
  di: Mie Waede, et al.
  Pubblicazione: (2024)
• Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors
  di: Saira Afzal, et al.
  Pubblicazione: (2024)
• Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis
  di: Monica Consonni, et al.
  Pubblicazione: (2024)
• Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
  di: Daisuke Ito, et al.
  Pubblicazione: (2024)